As a young pediatric oncologist, Dr. Pete Anderson was excited, yet at times terrified, about his chosen profession. On the one hand, he enjoyed the satisfaction of helping make kids healthy again. But on the other hand, he had the enormous responsibility of providing the care that their young lives depended on. During cancer treatment, many of his patients developed debilitating mouth sores that left them unable to eat. Frustrated with the complications his patients endured during the course of treatments, Dr. Anderson took matters into his own hands.
“I just knew I shouldn’t have to tell my patients that, ‘the chemo will make you better, but you’ll be in so much pain from the oral lesions that you’ll need a morphine drip.’”
The urgency to improve the standard of care for these young cancer patients is what led Dr. Anderson to the concept that became Healios™.
Healios™ was designed with his patients’ best interest at heart. Healios™ is a product that promotes and maintains the health of the epithelial cells and mucosal tissues of the digestive tract. Healios™’s formulation helps shuttle extra nitrogen into mucosal cells – a building block necessary for repair without which the mucosal cell dies.
While Healios™ was originally designed for oncologists, it has since been adopted by dental professionals wanting to help their patients who are healing from dental surgery. Healios™ has been shown in clinical trials to provide support to your body’s natural healing of the mucosal tissues of the gums and mouth.
Periodontal disease, abutments,dental surgery and implants all compromise the health of the mucosal tissue of the gums and mouth. There’s a strong correlation between oral health and your overall health. Ask your dental professional for Healios™ today.
Who discovered Healios™ ?
Peter M. Anderson, MD, PhD. who has served as a Professor, Department of Pediatrics Patient Care, Division of Pediatrics, Curtis Distinguished Professor, The University of Texas MD Anderson Cancer Center, Houston, TX originally developed the science and patents that formed the foundation for Healios™. Dr. Anderson is now at the Levine Cancer Institute/Levine Children’s Hospital in Charlotte, North Carolina.
How did Healios™ Oncology Nutrition come together?
After years of patient testing and refining the formula, Dr. Anderson partnered with a team of top oncologists and a world-class nutraceutical company to achieve his dream of making Healios™ available to patients world-wide. Dr. Anderson is on a mission to make Healios™ a part of the standard dietary regimen for those who need it, so that he can improve the lives of as many patients as possible.
Click Here For More Information About Dr. Anderson + -
Present Title & Affiliation
Director of Pediatric Hematology Oncology and Bone Marrow Transplant at the Levine Cancer Institute, Levine Children's Hospital.
- Carolinas HealthCare System
Education & Training
|1981||Mt. Sinai School of Medicine, New York, NY, MD, Medicine|
|1980||City University of New York, New York, NY, PHD, Biomedical Sciences|
|1975||University of Minnesota, Minneapolis, MN, BA, Summa Cum Laude, Psychology|
|1/1985-1/1988||Hematology/Oncology/Bone Marrow Transplant Fellowship, University of Minnesota, Minneapolis, MN|
|1/1981-1/1985||Combined Internal Medicine and Pediatrics Residency, Duke University Medical Center, Durham, NC|
Honors and Awards
|Alpha Omega Alpha, 1980|
|Career Development Award, American Cancer Society, 1989|
|Excellent in Teaching Award- Mayo Medical School, 2003|
|Annie Weber Memorial Lecture, MACC Fund, 2008|
|Curtis Distinguished Professor, 2009-2013|
|MD Anderson, Outstanding Patient Educator, 2010|
|MD Anderson Pediatric Physician Excellence in Teaching Award- from fellows 2012|
|MD Anderson Pediatric Physician Excellence in Teaching Award- from Residents 2012|
|Sarcoma Alliance Outstanding Care Award-2012|
|Kufos Lecture, Akron Children’s Hospital 2012|
|Visiting Lecturer, Midland Memorial Hospital, Midland TX 3-6-13 “ Sarcomas in young People”|
|Visiting Professor and Royal Dames of Ocala Lecture, University of Florida Shands Cancer Center and Univ FL Veterinary Teaching Hospital, Gainesville FL 4/10/13. “New Information to improve Pediatric Cancer Care and Sarcoma Care|
|American Society of Clinical Oncology
|American Society of Hematology
|American Society of Pediatric Hematology/Oncology
|Connective Tissue Oncology Society
|Sarcoma Alliance for Research through Collaboration (SARC)
|Societe Internationale D'Oncologie Pediatrique/ International Society of Paediatric Oncology